Michihiro Tsuchiya
Director/Board Member bei SUMITOMO ELECTRIC INDUSTRIES, LTD.
Profil
Michihiro Tsuchiya ist Mitglied des Vorstands von Sumitomo Electric Industries Ltd. und RaQualia Pharma, Inc. In der Vergangenheit hatte er die Position des Vorsitzenden der Mitsubishi Tanabe Pharma Corp. inne. Er erhielt einen Doktortitel von der Kyoto University.
Aktive Positionen von Michihiro Tsuchiya
| Unternehmen | Position | Beginn |
|---|---|---|
| SUMITOMO ELECTRIC INDUSTRIES, LTD. | Director/Board Member | 01.06.2018 |
| RAQUALIA PHARMA INC. | Director/Board Member | 26.03.2020 |
Ehemalige bekannte Positionen von Michihiro Tsuchiya
| Unternehmen | Position | Ende |
|---|---|---|
| MITSUBISHI CHEMICAL GROUP CORPORATION | Director/Board Member | - |
The Kaiteki Institute, Inc.
 The Kaiteki Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The Kaiteki Institute, Inc. engages in the research and investigation of social trends. It also involves in the research and development of new enterprises and operation and management of contract research. The company was founded on April 1, 2009 and is headquartered in Tokyo, Japan. | Director/Board Member | - |
| MITSUBISHI TANABE PHARMA CORPORATION | Chief Executive Officer | 01.04.2014 |
Ausbildung von Michihiro Tsuchiya
| Kyoto University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| SUMITOMO ELECTRIC INDUSTRIES, LTD. | Producer Manufacturing |
| MITSUBISHI CHEMICAL GROUP CORPORATION | Process Industries |
| RAQUALIA PHARMA INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Mitsubishi Tanabe Pharma Corp.
 Mitsubishi Tanabe Pharma Corp. Pharmaceuticals: OtherHealth Technology Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products. Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera. The company was founded by Gohei Tanabeya in 1678 and is headquartered in Osaka, Japan. | Health Technology |
The Kaiteki Institute, Inc.
The Kaiteki Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The Kaiteki Institute, Inc. engages in the research and investigation of social trends. It also involves in the research and development of new enterprises and operation and management of contract research. The company was founded on April 1, 2009 and is headquartered in Tokyo, Japan. | Commercial Services |
